Yener Koç

Dr. Yener Koc is award-wining expert in . Founder of the Transplant Center at Medicine International Istanbul. Was trained in the USA. Provides research studies for leukemia treatment. The team under his leadership has provided over 1,900 transplants.

Treatment results

Current long-term survival rates at his transplant center are:

• 66% — at 8 years for transplant patients with myeloma
• 78% — for sibling and unrelated transplants performed for patients with leukemia
• 75% — for haploidentical transplants for patients treated for leukemia in first remission, MDS and Hodgkin's lymphoma
• 80-90% — for thalassemia and aplastic anemia.
• Mortality rate for transplant is 6-9% for leukemia patients in first remission, and 0.5-1.7% for myeloma and lymphoma patients after autologous transplant.

Work experience

• Since 2020 — Founder of the Transplant Center at Medicana International Istanbul
• Since 2019 — expert in Medicana International Hospital Group
• 2008-2019 — specialist in Antalya Medical Park Hospital
• 2006-2008 — Chairman of Department of Internal Medicine at Yeditepe University School of Medicine.
• 2005 — Director of Hematology-Oncology Section and Founder of the comprehensive Transplant Unit at Yeditepe University School of Medicine.
• 2000-2005 — Founder and attending physician of the Transplant Unit at Institute of Oncology in Hacettepe University School of Medicine (Turkey)
• 1997-1999 — Instructor at the The Transplant Unit at Tufts University (USA)
• 1992-1999 — Research fellow and faculty member at the Evans Memorial Department at Boston University Medical Center (USA).

Education

• 1985 — Hacettepe University School (Turkey) —Degree in Genera Medicine
• 1996 — Boston University Medical Center (USA) — Specialty in Hematology Oncology
• 1999 — New England Medical Center (USA) — Specialty in Transplant.

Awards

• 1995 — Outstanding Physician Award by Boston University
• 1996 — Outstanding Physician Award by Boston University
• 1997 — Certification of Contribution to Science iby Prof. Dr. Kanti Rai (USA)
• 1997 — O-1 visa by Tufts University and the American Government for outstanding performance in medical science including new drug development in leukemia and lymphoma
• 2008 — International Healthcare Professional of the Year Award by International Biographical Institute (UK) forhis work in hematopoietic transplantation.

Scientific activities

• Dr. Koc has written over 230 scientific publications in hematology oncology and transplantation in international editions.
• Since 2004 — JACIE Accreditation Inspector for European Transplant Centers and International Society of Therapy.